Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol vs Prednisolone for Post-Cataract Inflammation in Children
NCT01475643Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 2013
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of loteprednol etabonate ophthalmic gel 0.38% in uveitis, sponsored by Bausch + Lomb. Started Jun 2013; status: completed.
02
Drugs
loteprednol etabonate ophthalmic gel 0.38%
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT01475643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475643.